Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Am J Hematol. 2018 Mar 30;93(6):760–768. doi: 10.1002/ajh.25085

Table 1.

Demographics of the cohort of children with normal transcranial Doppler (TCD) measurements (time averaged mean maximum velocity of < 200 cm/second, non-imaging or < 185 cm/second imaging technique) stratified by negative or positive MRI (n=421)

Variable* Normal TCD measurements, no evidence of silent cerebral infarct MRI (n=353) Normal TCD measurements, evidence of silent cerebral infarct (n=68) P Value*
Age at registration 8.9 (2.4) 9.1 (2.6) 0.437
Sex, Male (%) 49.6 54.4 0.465
Systolic blood pressure (n=416) 107.5 (11.8) 110.6 (10.5) 0.044
Steady state hemoglobin 8.3 (1.2) 7.9 (1.0) 0.006
Reticulocytes (%) (n=418) 11.6 (5.6) 14.3 (6.3) <0.001
Hydroxyurea use before end of follow-up (%) 25.2 23.5 0.769
Chronic transfusion before end of follow-up (%) 4.8 7.4 0.375#
Follow-up time until event, end-of study, or chronic transfusion, years 3.6 (1.3) 3.4 (1.5) 0.270
New neurological event (stroke, seizure or TIA) (%) 1.7 5.9 0.061#
Incidence rate, new neurological events (events/100 patient-years), 95% confidence interval 0.47 (0.17 – 1.02) 1.71 (0.46 – 4.37) 0.065§
*

Mean and standard deviation or chi-square test unless otherwise noted

#

Fisher’s exact test

§

Mid-p exact test